001     59689
005     20190625111848.0
024 7 _ |2 pmid
|a pmid:17333167
024 7 _ |2 DOI
|a 10.1007/s00253-007-0904-1
024 7 _ |2 WOS
|a WOS:000248893700015
024 7 _ |2 ISSN
|a 0175-7598
024 7 _ |a altmetric:21818157
|2 altmetric
037 _ _ |a PreJuSER-59689
041 _ _ |a eng
082 _ _ |a 570
084 _ _ |2 WoS
|a Biotechnology & Applied Microbiology
100 1 _ |a Blombach, B.
|b 0
|0 P:(DE-HGF)0
245 _ _ |a Effect of pyruvate dehydrogenase complex deficiency on L-lysine production with Corynebacterium glutamicum
260 _ _ |c 2007
|a Berlin
|b Springer
300 _ _ |a 615 - 623
336 7 _ |a Journal Article
|0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
440 _ 0 |a Applied Microbiology and Biotechnology
|x 0175-7598
|0 555
|y 3
|v 76
500 _ _ |a Record converted from VDB: 12.11.2012
520 _ _ |a Intracellular precursor supply is a critical factor for amino acid productivity of Corynebacterium glutamicum. To test for the effect of improved pyruvate availability on L-lysine production, we deleted the aceE gene encoding the E1p enzyme of the pyruvate dehydrogenase complex (PDHC) in the L-lysine-producer C. glutamicum DM1729 and characterised the resulting strain DM1729-BB1 for growth and L-lysine production. Compared to the host strain, C. glutamicum DM1729-BB1 showed no PDHC activity, was acetate auxotrophic and, after complete consumption of the available carbon sources glucose and acetate, showed a more than 50% lower substrate-specific biomass yield (0.14 vs 0.33 mol C/mol C), an about fourfold higher biomass-specific L-lysine yield (5.27 vs 1.23 mmol/g cell dry weight) and a more than 40% higher substrate-specific L-lysine yield (0.13 vs 0.09 mol C/mol C). Overexpression of the pyruvate carboxylase or diaminopimelate dehydrogenase genes in C. glutamicum DM1729-BB1 resulted in a further increase in the biomass-specific L-lysine yield by 6 and 56%, respectively. In addition to L-lysine, significant amounts of pyruvate, L-alanine and L-valine were produced by C. glutamicum DM1729-BB1 and its derivatives, suggesting a surplus of precursor availability and a further potential to improve L-lysine production by engineering the L-lysine biosynthetic pathway.
536 _ _ |a Biotechnologie
|c PBT
|2 G:(DE-HGF)
|0 G:(DE-Juel1)FUEK410
|x 0
588 _ _ |a Dataset connected to Web of Science, Pubmed
650 _ 2 |2 MeSH
|a Base Sequence
650 _ 2 |2 MeSH
|a Biotechnology
650 _ 2 |2 MeSH
|a Corynebacterium glutamicum: genetics
650 _ 2 |2 MeSH
|a Corynebacterium glutamicum: growth & development
650 _ 2 |2 MeSH
|a Corynebacterium glutamicum: metabolism
650 _ 2 |2 MeSH
|a DNA, Bacterial: genetics
650 _ 2 |2 MeSH
|a Fermentation
650 _ 2 |2 MeSH
|a Gene Deletion
650 _ 2 |2 MeSH
|a Gene Expression
650 _ 2 |2 MeSH
|a Genes, Bacterial
650 _ 2 |2 MeSH
|a Kinetics
650 _ 2 |2 MeSH
|a Lysine: biosynthesis
650 _ 2 |2 MeSH
|a Pyruvate Dehydrogenase Complex: genetics
650 _ 2 |2 MeSH
|a Pyruvate Dehydrogenase Complex: metabolism
650 _ 7 |0 0
|2 NLM Chemicals
|a DNA, Bacterial
650 _ 7 |0 0
|2 NLM Chemicals
|a Pyruvate Dehydrogenase Complex
650 _ 7 |0 56-87-1
|2 NLM Chemicals
|a Lysine
650 _ 7 |a J
|2 WoSType
653 2 0 |2 Author
|a Corynebacterium glutamicum
653 2 0 |2 Author
|a L-lysine
653 2 0 |2 Author
|a pyruvate dehydrogenase complex
653 2 0 |2 Author
|a L-lysine production
700 1 _ |a Schreiner, M. E.
|b 1
|0 P:(DE-HGF)0
700 1 _ |a Moch, M.
|b 2
|u FZJ
|0 P:(DE-Juel1)VDB23977
700 1 _ |a Oldiges, M.
|b 3
|u FZJ
|0 P:(DE-Juel1)129053
700 1 _ |a Eikmanns, B. J.
|b 4
|0 P:(DE-HGF)0
773 _ _ |0 PERI:(DE-600)1464336-4
|a 10.1007/s00253-007-0904-1
|g Vol. 76, p. 615 - 623
|p 615 - 623
|q 76<615 - 623
|t Applied Microbiology and Biotechnology
|v 76
|x 0175-7598
|y 2007
856 7 _ |u http://dx.doi.org/10.1007/s00253-007-0904-1
909 C O |o oai:juser.fz-juelich.de:59689
|p VDB
913 1 _ |k PBT
|v Biotechnologie
|l ohne FE
|b außerhalb PoF
|0 G:(DE-Juel1)FUEK410
|x 0
914 1 _ |y 2007
915 _ _ |a JCR/ISI refereed
|0 StatID:(DE-HGF)0010
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
920 1 _ |k IBT-2
|l Biotechnologie 2
|g IBT
|z ab 31.10.10 weitergeführt IBG-1
|0 I:(DE-Juel1)VDB56
|x 1
970 _ _ |a VDB:(DE-Juel1)93804
980 _ _ |a VDB
980 _ _ |a ConvertedRecord
980 _ _ |a journal
980 _ _ |a I:(DE-Juel1)IBG-1-20101118
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBG-1-20101118


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21